Vitalyst
Payments companies reported to CMS as associated with Vitalyst. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vitalyst, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vitalyst
These are the largest totals companies reported as associated with Vitalyst. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $19,819.87 |
| Brian Bergmark | Boston, MA | Cardiovascular Disease | $5,193.62 |
| Grant Reed | Cleveland, OH | Interventional Cardiology | $5,118.12 |
| Hector Tamez Aguilar | Boston, MA | Interventional Cardiology | $5,101.24 |
| Kamran Muhammad | Tulsa, OK | Interventional Cardiology | $4,908.67 |
| Zubair Khan | Las Vegas, NV | Interventional Cardiology | $4,777.75 |
| Leon Varjabedian | Las Vegas, NV | Interventional Cardiology | $4,470.29 |
| Justin Dunn | Akron, OH | Interventional Cardiology | $4,408.67 |
| Anene Ukaigwe | Charleston, WV | Interventional Cardiology | $4,369.19 |
| Daniel Burkhoff | Saddlebrook, NJ | $4,268.06 |
Prescribed Vitalyst?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.